Apyx Medical Corp (APYX) Return on equity 2016–2025
Apyx Medical Corp (APYX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-77.1%FY2025 · since FY2016: -44.0% → -77.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -77.1% | +88.0 pp |
| FY2024 | -165.1% | -95.0 pp |
| FY2023 | -70.1% | -8.4 pp |
| FY2022 | -61.7% | -33.4 pp |
| FY2021 | -28.3% | -9.6 pp |
| FY2020 | -18.7% | +9.0 pp |
| FY2019 | -27.7% | -99.6 pp |
| FY2018 | 71.9% | +94.9 pp |
| FY2017 | -23.0% | +21.1 pp |
| FY2016 | -44.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More APYX financial trends
APYX RevenueAPYX Net incomeAPYX Net marginAPYX Gross profitAPYX Gross marginAPYX Operating incomeAPYX Operating marginAPYX Operating cash flowAPYX Free cash flowAPYX Capital expendituresAPYX Stock buybacksAPYX Dividends paidAPYX Total assetsAPYX Total liabilitiesAPYX Shareholders’ equityAPYX overview →